Vera Therapeutics paid its 5 named executives $17.5M in total in FY2025 (Dec). CEO Marshall Fordyce, M.D. was paid $7.0M of that.
Pay$100 in the stock at the end of FY21 → $190
Pay of each named executive
Marshall Fordyce, M.D.President and Chief Executive Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed |
4 years
David Johnson, M.B.A.Chief Operating Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | Not disclosed |
3 years
Robert Brenner, M.D.Chief Medical Officer
| FY2025 (Dec) | |||||||
| FY2023 (Dec) | Not disclosed |
2 years
Sean GrantChief Financial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed |
4 years
William TurnerChief Regulatory Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | Not disclosed |
3 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 8 peers with pay on file was $9.0M. The CEO of Vera Therapeutics was paid $7.0M, 23% below the median.
- 1Cogent Biosciences
- 2Protagonist Therapeutics
- 3Immunovant
- 4IDEAYA Biosciences
- 5Kymera Therapeutics
- 6Structure Therapeutics
- 7Vera TherapeuticsThis company
- 8Spyre Therapeutics
- 9Celldex Therapeutics
- 10Akero Therapeutics Inc.Not disclosed
- 11AnaptysBio Inc.Not disclosed
- 12Arcellx Inc.Not disclosed
- 13Avidity Biosciences Inc.Not disclosed
- 14Crinetics Pharmaceuticals Inc.Not disclosed
- 15Neumora Therapeutics Inc.Not disclosed
- 16Pliant Therapeutics Inc.Not disclosed
- 17Soleno Therapeutics Inc.Not disclosed
- 18Summit TherapeuticsNot disclosed
- 19Syndax PharmaceuticalsNot disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.